Patent application number | Description | Published |
20090318356 | METHODS AND COMPOSITIONS FOR CONTROL OF FETAL GROWTH VIA MODULATION OF RELAXIN - The invention relates to the method for treatment, diagnosis and prevention of diseases related to fetal growth and placental insufficiency and comprises methods including inhibiting or increasing relaxin synthesis, relaxin receptor synthesis, relaxin binding to the relaxin receptor, and relaxin receptor activity. The invention also relates to screening assays to identify compounds that modulate relaxin and/or relaxin receptor activity. The invention further relates to gene therapy methods utilizing relaxin and relaxin-related sequences for the treatment and prevention of diseases related to fetal growth and placental insufficiency. | 12-24-2009 |
20100048475 | Method of Treating Dyspnea Associated with Acute Heart Failure - The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin. | 02-25-2010 |
20110144019 | METHOD OF TREATING CHRONIC HEART FAILURE - The present disclosure relates to methods for treating human subjects afflicted with chronic heart failure. The methods described herein employ administration of relaxin. | 06-16-2011 |
20120040902 | METHOD OF TREATING DYSPNEA ASSOCIATED WITH ACUTE HEART FAILURE - The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin. | 02-16-2012 |
20120040903 | METHOD FOR TREATING DYSPNEA ASSOCIATED WITH ACUTE HEART FAILURE - The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin. | 02-16-2012 |
20130116181 | Method of treating dyspnea associated with acute heart failure - The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin. | 05-09-2013 |
20130210730 | METHOD OF TREATING DYSPNEA ASSOCIATED WITH ACUTE HEART FAILURE - The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin. | 08-15-2013 |
20140005112 | METHOD OF TREATING CHRONIC HEART FAILURE BY ADMINISTERING RELAXIN | 01-02-2014 |